Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Britain Unleashed: our world-class universities can lead us to prosperity

27 July 2012

Britain’s universities are international powerhouses of research, innovation and education – used properly they can and will sustain immediate and long term economic prosperity, says Stephen Caddick.

Read the full article at www.telegraph.co.uk